Literature DB >> 21385741

Effects of fibrin, thrombin, and blood on breast capsule formation in a preclinical model.

Marisa Marques1, Spencer A Brown, Natália D S Cordeiro, Pedro Rodrigues-Pereira, M Luís Cobrado, Aliuska Morales-Helguera, Nuno Lima, André Luís, Mário Mendanha, Acácio Gonçalves-Rodrigues, José Amarante.   

Abstract

BACKGROUND: The root cause of capsular contracture (CC) associated with breast implants is unknown. Recent evidence points to the possible role of fibrin and bacteria in CC formation.
OBJECTIVES: The authors sought to determine whether fibrin, thrombin, and blood modulated the histological and microbiological outcomes of breast implant capsule formation in a rabbit model.
METHODS: The authors carried out a case-control study to assess the influence of fibrin, thrombin, and blood on capsule wound healing in a rabbit model. Eighteen New Zealand white rabbits received four tissue expanders. One expander acted as a control, whereas the other expander pockets received one of the following: fibrin glue, rabbit blood, or thrombin sealant. Intracapsular pressure/volume curves were compared among the groups, and histological and microbiological evaluations were performed (capsules, tissue expanders, rabbit skin, and air). The rabbits were euthanized at two or four weeks.
RESULTS: At four weeks, the fibrin and thrombin expanders demonstrated significantly decreased intracapsular pressure compared to the control group. In the control and fibrin groups, mixed inflammation correlated with decreased intracapsular pressure, whereas mononuclear inflammation correlated with increased intracapsular pressure. The predominant isolate in the capsules, tissue expanders, and rabbit skin was coagulase-negative staphylococci. For fibrin and thrombin, both cultures that showed an organism other than staphylococci and cultures that were negative were associated with decreased intracapsular pressure, whereas cultures positive for staphylococci were associated with increased intracapsular pressure.
CONCLUSIONS: Fibrin application during breast implantation may reduce rates of CC, but the presence of staphylococci is associated with increased capsule pressure even in the presence of fibrin, so care should be taken to avoid bacterial contamination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21385741     DOI: 10.1177/1090820X11398351

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  5 in total

1.  A Forgotten Entity following Breast Implant Contracture: Does Baker Need a Change?

Authors:  Andrea Pagani; Matthias M Aitzetmüller; Lorenz Larcher
Journal:  Arch Plast Surg       Date:  2022-05-27

2.  Histologic, Molecular, and Clinical Evaluation of Explanted Breast Prostheses, Capsules, and Acellular Dermal Matrices for Bacteria.

Authors:  Louis Poppler; Justin Cohen; Utku Can Dolen; Andrew E Schriefer; Marissa M Tenenbaum; Corey Deeken; Richard A Chole; Terence M Myckatyn
Journal:  Aesthet Surg J       Date:  2015-08       Impact factor: 4.283

Review 3.  Capsular Contracture after Breast Augmentation: An Update for Clinical Practice.

Authors:  Hannah Headon; Adbul Kasem; Kefah Mokbel
Journal:  Arch Plast Surg       Date:  2015-09-15

4.  Follistatin and the Breast Implant Capsule.

Authors:  Brett A Frenkiel; Peter Temple-Smith; David de Kretser; Graeme J Southwick
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-03-01

5.  The Histological Composition of Capsular Contracture Focussed on the Inner Layer of the Capsule: An Intra-Donor Baker-I Versus Baker-IV Comparison.

Authors:  E de Bakker; L J van den Broek; M J P F Ritt; S Gibbs; F B Niessen
Journal:  Aesthetic Plast Surg       Date:  2018-09-05       Impact factor: 2.326

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.